logo
Select company
Select metric
$ -389.92MConsolidated Income
VS
Market
3
Sector
4
Industry
4
History
20
$ 2.27Close
$ 1.66 - $ 12.28 52-Week Range
Ticker Information

Ticker

IOVA

Company Name

IOVANCE BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

IOVANCE BIOTHERAPEUTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IOVA - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -389.92M
3/31/2025$ -375.36M
12/31/2024$ -372.18M
9/30/2024$ -410M
6/30/2024$ -440.22M
3/31/2024$ -449.64M
12/31/2023$ -444.04M
9/30/2023$ -432.98M
6/30/2023$ -418.83M
3/31/2023$ -411.66M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IOVANCE BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -254.75M.
  • Over the past 5 years, IOVANCE BIOTHERAPEUTICS INC's average Cons. Inc. has been $ -369.13M.
  • The median Cons. Inc. for IOVANCE BIOTHERAPEUTICS INC during this period was $ -383.16M
  • IOVANCE BIOTHERAPEUTICS INC reached its highest Cons. Inc. over the past 5 years at $ -254.75M.
  • The lowest Cons. Inc. recorded by IOVANCE BIOTHERAPEUTICS INC in the same timeframe $ -449.64M

IOVANCE BIOTHERAPEUTICS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
XERS : XERIS BIOPHARMA HOLDINGS INC $ -32MRCUS : ARCUS BIOSCIENCES INC $ -298MDNA : GINKGO BIOWORKS HOLDINGS INC $ -315.19MAKBA : AKEBIA THERAPEUTICS INC $ -36.48MAUPH : AURINIA PHARMACEUTICALS INC $ 60.64MMNKD : MANNKIND CORP $ 32.8MGERN : GERON CORP $ -88.01MSTOK : STOKE THERAPEUTICS INC $ 52.48MKROS : KEROS THERAPEUTICS INC $ 18.77MDAWN : DAY ONE BIOPHARMACEUTICALS INC $ -95M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

IOVA - Consolidated Income, Last 5 years

$ -449.64M

Minimum

Mar 31, 2024

$ -254.75M

Maximum

Sep 30, 2020

$ -369.13M

Average

$ -383.16M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.01M with a standard deviation of $ 116.51M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.01M
median$ -2.1M
std$ 116.51M